SI
MRVI icon

Sprott Inc’s Maravai LifeSciences MRVI Stock Holding History

Sprott Inc’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.3K Hold
10,000
– – ﹤0.01% 235
2025
Q4 		$32.5K Hold
10,000
– – ﹤0.01% 211
2025
Q3 		$28.7K Buy
+10,000
New +$25.5K ﹤0.01% 205

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sprott Inc's MRVI Position: Q1 2026 in Review

Sprott Inc held its Maravai LifeSciences (MRVI) position steady in Q1 2026 at 10,000 shares worth $28.3K. The position accounts for ﹤0.01% of the portfolio, ranked #235.

Sprott Inc first reported a position in MRVI in Q3 2025 and has held it in 3 quarters since. The position peaked at $32.5K in Q4 2025. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Sprott Inc held 10,000 shares of Maravai LifeSciences worth $28.3K as of Q1 2026.
  • Sprott Inc left its Maravai LifeSciences share count unchanged in Q1 2026.
  • Maravai LifeSciences made up ﹤0.01% of Sprott Inc's portfolio in Q1 2026, its #235 holding.
  • Sprott Inc first reported a position in Maravai LifeSciences in Q3 2025 and has held it in 3 quarters since.
  • Sprott Inc's Maravai LifeSciences position peaked at $32.5K in Q4 2025.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Sprott Inc's 13F filing for Q1 2026, filed 8 May 2026.